Recent developments with immunotherapy for hepatocellular carcinoma
Author:
Affiliation:
1. Medizinische Klinik 1, Universitätsklinikum Frankfurt, Frankfurt, Germany
Publisher
Informa UK Limited
Subject
Clinical Biochemistry,Drug Discovery,Pharmacology
Link
https://www.tandfonline.com/doi/pdf/10.1080/14712598.2018.1499722
Reference48 articles.
1. Sorafenib in Advanced Hepatocellular Carcinoma
2. EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
3. Novel drugs in clinical development for hepatocellular carcinoma
4. Role of regorafenib as second-line therapy and landscape of investigational treatment options in advanced hepatocellular carcinoma
5. Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
Cited by 90 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Exploring the impact of circRNAs on cancer glycolysis: Insights into tumor progression and therapeutic strategies;Non-coding RNA Research;2024-09
2. Advancements in Immunotherapeutic Treatments for Hepatocellular Carcinoma: Potential of Combination Therapies;International Journal of Molecular Sciences;2024-06-21
3. Assessment of safety and efficacy of transarterial chemoembolization combined with camrelizumab and donafenib in patients with hepatocellular carcinoma at BCLC stage C: A study of 20 cases;Medicine;2024-05-17
4. Single-cell data revealed exhaustion of characteristic NK cell subpopulations and T cell subpopulations in hepatocellular carcinoma;Aging;2024-04-05
5. PRMT1 Integrates Immune Microenvironment and Fatty Acid Metabolism Response in Progression of Hepatocellular Carcinoma;Journal of Hepatocellular Carcinoma;2024-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3